Skip to main content
. 2018 Apr 3;2018(4):CD010597. doi: 10.1002/14651858.CD010597.pub2

Power 2009.

Methods
  • Study design: quasi‐RCT

  • Study duration: not reported

  • Duration of follow‐up: not reported

Participants
  • Setting: multicentre (4)

  • Country: UK

  • Participants who had been on dialysis therapy for longer than 90 days

  • Number (participants/catheters): treatment group (132/132); control group (100/100)

  • Mean age ± SD (years): treatment group I (63 ± 14); control group (62 ± 13)

  • Sex (M/F): treatment group (73/59); control group (59/41)

  • Exclusion criteria: bleeding diathesis; an intervention, or pathological state within 3 months of entry that would heighten the risk of bleeding; hypocalcaemia

Interventions Treatment group
  • Sodium citrate: 46.7%


Control group
  • Heparin: 5000 U/mL

Outcomes
  • CRI

  • Catheter dysfunction

Notes
  • Funding source: None

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Single random‐ numbers method of odd and even numbers
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Insufficient information to permit judgement
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Insufficient information to permit judgement
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk All patient data reported
Selective reporting (reporting bias) High risk Outcomes of interest reported incompletely
Other bias Unclear risk Insufficient information to permit judgement